Navigation Links
Visionsense Announces Food and Drug Administration (FDA) 510(k) Clearance for VSII - Visionsense Stereoscopic Vision System

ORANGEBURG, N.Y., March 18 /PRNewswire/ -- Visionsense Corp. announces FDA 510(k) Clearance of the new VSII -- Visionsense Stereoscopic Vision System. The system is based on a miniature 3.4 mm distal ("chip-on-a-stick") stereoscopic 3D camera targeting Minimal Invasive laparoscopic and endoscopic Surgery (MIS).

Visionsense's stereoscopic 3D camera enables and enhances MIS surgical procedures that are under served by traditional 2D visualization, in markets such as: Spine, Neurosurgery, Orthopedics, Endoscopy, General Surgery, GYN, Robotics, and others.

The company has licensed the technology to various strategic marketing partners, expecting launches later this year.

About Visionsense Corp.

Visionsense exclusively licenses its technology, application or segment specific, to strategic partners, benefiting a unique competitive advantage. The Company develops and manufactures customized Miniature Stereoscopic 3D cameras/sensors that enable surgeons to see "natural" Stereovision, thus enhancing image understanding and hand-eye coordination. These re-useable or disposable cameras are distally assembled on the tip of a flexible / rigid scope or instrument. The technology further assists the surgeon by providing advanced software features, such as image fusion (combining stereovision with MRI, CT or ultrasound for real-time "see-through-tissue") and 3D measurements.

For more information please call:

Joe Rollero

Executive Vice President

Business Development

Visionsense Corp.

40 Ramland Road, Suite 202

Orangeburg, NY 10962

Phone: 845-680-0233


SOURCE Visionsense Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing of ... team leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman ... AngelList early in their initial angel funding process. Now, they are paying it ... to make early stage investments in the microbiome space. In this, they ...
Breaking Biology Technology:
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
(Date:11/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), the ... entry into the automotive market with a comprehensive and ... of consumer electronics human interface innovation. Synaptics, industry-leading touch ... the automotive industry and will be implemented in numerous ... , Japan , and ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):